Hubbry Logo
PerfusionPerfusionMain
Open search
Perfusion
Community hub
Perfusion
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Perfusion
Perfusion
Perfusion
View on Wikipedia
from Wikipedia
A Lindbergh perfusion pump, c. 1935, an early device for simulating natural perfusion

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue,[1] usually referring to the delivery of blood to a capillary bed in tissue. Perfusion may also refer to fixation via perfusion, used in histological studies. Perfusion is measured as the rate at which blood is delivered to tissue,[2] or volume of blood per unit time (blood flow) per unit tissue mass. The SI unit is m3/(s·kg)[citation needed], although for human organs perfusion is typically reported in ml/min/g.[3] The word is derived from the French verb perfuser, meaning to "pour over or through".[4] All animal tissues require an adequate blood supply for health and life. Poor perfusion (malperfusion), that is, ischemia, causes health problems, as seen in cardiovascular disease, including coronary artery disease, cerebrovascular disease, peripheral artery disease, and many other conditions.

Tests verifying that adequate perfusion exists are a part of a patient's assessment process that are performed by medical or emergency personnel. The most common methods include evaluating a body's skin color, temperature, condition (dry/soft/firm/swollen/sunken/etc), and capillary refill.

During major surgery, especially cardiothoracic surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone. As the lead surgeons are often too busy to handle all hemodynamic control by themselves, specialists called perfusionists manage this aspect. There are more than one hundred thousand perfusion procedures annually.[5]

Discovery

[edit]

In 1920, August Krogh was awarded the Nobel Prize in Physiology or Medicine for discovering the regulation mechanism of capillaries in skeletal muscle.[6][7] Krogh was the first to describe the adaptation of blood perfusion in muscle and other organs according to demands through the opening and closing of arterioles and capillaries.[citation needed]

Malperfusion

[edit]

Malperfusion can refer to any type of incorrect perfusion though it usually refers to hypoperfusion. The meaning of the terms "overperfusion" and "underperfusion" is relative to the average level of perfusion that exists across all the tissues in an individual body. Perfusion levels also differ from person to person depending on metabolic demand.[citation needed]

Examples follow:[citation needed]

  • Heart tissues are considered overperfused because they normally are receiving more blood than the rest of tissues in the organism; they need this blood because they are constantly working.
  • In the case of skin cells, extra blood flow in them is used for thermoregulation of a body. In addition to delivering oxygen, blood flow helps to dissipate heat in a body by redirecting warm blood closer to its surface where it can help to cool a body through sweating and thermal dissipation.
  • Many types of tumors, and especially certain types, have been described as "hot and bloody" because of their overperfusion relative to the body overall.

Overperfusion and underperfusion should not be confused with hypoperfusion and hyperperfusion, which relate to the perfusion level relative to a tissue's current need to meet its metabolic needs. For example, hypoperfusion can be caused when an artery or arteriole that supplies blood to a volume of tissue becomes blocked by an embolus, causing either no blood or at least not enough blood to reach the tissue. Hyperperfusion can be caused by inflammation, producing hyperemia of a body part. Malperfusion, also called poor perfusion, is any type of incorrect perfusion. There is no official or formal dividing line between hypoperfusion and ischemia; sometimes the latter term refers to zero perfusion, but often it refers to any hypoperfusion that is bad enough to cause necrosis.[citation needed]

Measurement

[edit]
Main article: Perfusion scanning

In equations, the symbol Q is sometimes used to represent perfusion when referring to cardiac output. However, this terminology can be a source of confusion since both cardiac output and the symbol Q refer to flow (volume per unit time, for example, L/min), whereas perfusion is measured as flow per unit tissue mass (mL/(min·g)).[citation needed]

Microspheres

[edit]
Main article: Microspheres

Microspheres that are labeled with radioactive isotopes have been widely used to measure perfusion since the 1960s. Radioactively labeled particles are injected into the test subject and a radiation detector measures radioactivity in tissues of interest.[8] Microspheres are used in radionuclide angiography, a method of diagnosing heart problems.

In the 1990s, methods for using fluorescent microspheres became a common substitute for radioactive particles.[9]

Nuclear medicine

[edit]
Main article: Nuclear medicine

Perfusion of various tissues can be readily measured in vivo with nuclear medicine methods which are mainly positron emission tomography (PET) and single photon emission computed tomography (SPECT).[citation needed] Various radiopharmaceuticals targeted at specific organs are also available, some of the most common are:[citation needed]

Magnetic resonance imaging

[edit]
Main article: Magnetic resonance imaging

Two main categories of magnetic resonance imaging (MRI) techniques can be used to measure tissue perfusion in vivo.

  • The first is based on the use of an injected contrast agent that changes the magnetic susceptibility of blood and thereby the MR signal which is repeatedly measured during bolus passage.[10]
  • The other category is based on arterial spin labelling (ASL), where arterial blood is magnetically tagged before it enters into the tissue being examined and the amount of labelling that is measured and compared to a control recording obtained without spin labelling.[11]

Computed tomography (CT)

[edit]
Main article: Computed tomography

Brain perfusion (more correctly transit times) can be estimated with contrast-enhanced computed tomography.[12]

Thermal diffusion

[edit]
Main article: Molecular diffusion

Perfusion can be determined by measuring the total thermal diffusion and then separating it into thermal conductivity and perfusion components.[13] rCBF is usually measured continuously in time. It is necessary to stop the measurement periodically to cool down and reassess the thermal conductivity.[citation needed]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Perfusion

View on Grokipedia
from Grokipedia
Perfusion is the passage of bodily fluids, such as , through the circulatory or to an organ or tissue, ensuring the supply of oxygen and nutrients while facilitating the removal of products. This fundamental biological function is essential for maintaining cellular and is quantified as the rate of flow per unit of tissue mass, typically expressed in milliliters per minute per 100 grams of tissue. Inadequate perfusion, known as hypoperfusion, can lead to tissue ischemia and , whereas hyperperfusion may cause or hemorrhage, underscoring its critical role in health and disease. In clinical medicine, perfusion extends beyond natural physiology to include diagnostic and therapeutic applications. Perfusion imaging techniques, such as magnetic resonance perfusion and nuclear scintigraphy, are used to assess blood flow in organs like the brain, heart, and lungs, aiding in the diagnosis of conditions including stroke, coronary artery disease, and pulmonary embolism. Therapeutically, extracorporeal perfusion systems, operated by cardiovascular perfusionists, temporarily take over the heart and lungs' functions during open-heart surgery by circulating oxygenated blood through an external circuit. Machine perfusion is also employed in organ transplantation to preserve donor organs ex vivo under controlled conditions, improving viability and expanding the donor pool. The study and management of perfusion involve multidisciplinary approaches, integrating principles from , , and . Factors influencing perfusion include , , and gravitational effects, with regional variations often assessed via the ventilation-perfusion ratio in the lungs to optimize . Advances in perfusion technology continue to evolve, particularly in critical care settings like and trauma, where monitoring tools such as provide real-time insights into tissue oxygenation.

Fundamentals

Definition

Perfusion is a physiological involving the passage of or other fluids through the to deliver oxygen, nutrients, and hormones to tissues while facilitating the removal of metabolic waste products such as and lactate. The term derives from the Latin perfusio, meaning "a pouring through" or "to pour over," reflecting the concept of fluid permeating a structure. In medical and physiological contexts, perfusion specifically refers to the bulk flow of through capillaries and microvasculature, ensuring adequate supply to meet tissue demands. A key distinction exists between perfusion and diffusion: perfusion entails the convective, pressure-driven bulk movement of within vessels to reach tissue beds, whereas is the passive molecular transport across membranes driven by concentration gradients, such as the exchange of oxygen from erythrocytes to parenchymal cells. This separation underscores perfusion's role in macroscopic delivery and 's in microscopic transfer. Perfusion is quantified as the rate of flow per unit tissue or , often denoted as QQ, calculated simply as Q=[blood](/page/Blood+) flowtissue [mass](/page/Mass)Q = \frac{\text{[blood](/page/Blood+) flow}}{\text{tissue [mass](/page/Mass)}}. Common units include milliliters per minute per gram (mL/min/g) of tissue, accounting for variations in tissue . For example, in a resting adult with a of approximately 5 L/min, perfusion varies by organ to match metabolic needs; the kidneys, for instance, receive about 20% of total , yielding a perfusion rate of roughly 3–4 mL/min/g to support glomerular filtration. Such distribution highlights perfusion's adaptive nature in maintaining organ .

Physiological Role

Perfusion plays a critical role in delivering oxygen and essential nutrients to tissues, enabling aerobic and sustaining cellular function. Through the , blood flow transports oxygen bound to and dissolved nutrients such as glucose directly to beds, where they diffuse into spaces and cells to support energy production via . This process is quantified by the , which states that oxygen consumption (VO₂) equals or perfusion rate (Q) multiplied by the arterial-venous oxygen content difference (VO₂ = Q × (CaO₂ - CvO₂)), highlighting how perfusion rate directly influences tissue oxygenation. Beyond nutrient supply, perfusion facilitates the removal of metabolic waste products, including (CO₂) and lactate, preventing accumulation that could lead to and cellular dysfunction. Blood flow carries these byproducts from tissues back to the lungs for CO₂ or to the liver and kidneys for lactate processing, maintaining acid-base balance. Additionally, perfusion contributes to by distributing heat generated in metabolically active organs to the skin and periphery, where or modulates heat loss through and to stabilize core body temperature. Perfusion demands vary by organ to match metabolic requirements, with autoregulation ensuring stable blood flow despite fluctuations in systemic pressure. For instance, the receives approximately 750 mL/min to support high oxygen needs for neuronal activity, while the kidneys get about 1000 mL/min to facilitate and . This targeted distribution underscores perfusion's role in preserving organ-specific . In the lungs, perfusion integrates with ventilation to optimize , as described by the ventilation-perfusion (V/Q) ratio, ideally near 0.8 overall, which balances alveolar air flow (V) with capillary blood flow (Q) to maximize oxygen uptake and CO₂ elimination.

Historical Development

Early Concepts

The foundational concepts of perfusion emerged from ancient observations of blood flow, with the Roman physician (c. 129–c. 200 AD) proposing that blood originated in the liver and was distributed centrifugally through the venous system to nourish peripheral tissues, a view that emphasized blood's role in vital processes without recognizing a closed circulatory loop. This theory persisted through the , influencing early understandings of how blood reached organs and muscles, though it lacked empirical validation of directional flow dynamics essential to perfusion. During the Renaissance, William Harvey revolutionized these ideas with his 1628 publication De Motu Cordis et Sanguinis in Animalibus, where he demonstrated through quantitative dissections and vivisections that blood circulates continuously in a closed system propelled by the heart, providing the mechanistic basis for perfusion as the targeted delivery of arterial blood to tissues for oxygenation and nutrient exchange. Harvey's work shifted focus from static distribution to dynamic flow, highlighting the heart's pumping action as central to maintaining tissue viability, though direct measurement of local perfusion remained elusive. Building on this, Marcello Malpighi observed capillaries in the lung of a frog in 1661, providing the first microscopic evidence of blood flow through the microvasculature and completing the circulatory loop at the tissue level. The 19th century brought experimental rigor to perfusion studies, exemplified by Claude Bernard's investigations in the early 1850s, which revealed vasomotor nerves' control over tone; by sectioning the cervical sympathetic nerve in 1851, Bernard observed and increased local blood flow in the ear of rabbits, establishing neural regulation as a key mechanism for adapting perfusion to environmental or metabolic demands. These findings underscored perfusion's responsiveness, linking it to rather than mere circulation. Pioneering animal experiments further illuminated perfusion at the tissue level, with researchers in the 1800s injecting colored dyes—such as carmine or indigo solutions—into the vascular systems of frogs and mammals to trace capillary pathways and assess flow distribution under the microscope, often in transparent tissues like frog mesentery or tongue. These methods allowed visualization of blood's passage through microvasculature, confirming Harvey's circulatory model at the peripheral scale and revealing perfusion gradients influenced by vessel diameter and pressure. A pivotal enabler was the 1846 public demonstration of ether anesthesia by William T.G. Morton, which permitted prolonged surgical and observational studies of blood flow in intact animals without distress, facilitating detailed intraoperative assessments of tissue perfusion. In 1895, Oscar Langendorff developed the isolated perfused heart preparation, allowing controlled study of coronary blood flow and cardiac function ex vivo in mammalian hearts.

Key Advancements

One of the most transformative advancements in perfusion technology occurred in 1953 when John H. Gibbon Jr. invented the machine, which facilitated the first successful open-heart surgery by providing controlled extracorporeal perfusion to oxygenate blood and maintain circulation during procedures that temporarily halt the heart. This innovation revolutionized , enabling complex interventions previously impossible due to the need for uninterrupted blood flow and oxygenation. In the 1960s, studies on advanced significantly through electron microscopy techniques pioneered by Guido Majno and George E. Palade, who elucidated key dynamics, particularly how and serotonin induce endothelial contraction to increase during . Their work provided foundational insights into the ultrastructural mechanisms governing nutrient and oxygen delivery at the tissue level, influencing subsequent on microvascular function and . The 1970s marked the introduction of computed tomography (CT) as a pioneering tool for quantitative perfusion assessment, with early CT perfusion techniques emerging in 1979 to measure cerebral blood flow dynamics via contrast-enhanced sequential scans. Magnetic resonance imaging (MRI), also developed in the 1970s, enabled non-invasive perfusion assessment starting in the 1990s. These modalities shifted perfusion evaluation from invasive methods to non-invasive imaging, allowing precise mapping of regional blood flow and volume in clinical settings like stroke diagnosis. Advancements in the and focused on isolated organ perfusion for transplantation, notably normothermic perfusion (NMP), which maintains organs at body temperature with oxygenated blood to mitigate ischemia-reperfusion injury; the first successful clinical applications in occurred in 2016, demonstrating improved graft viability and expanded donor pools. This technique has since reduced post-transplant complications by allowing real-time organ assessment and resuscitation, particularly for marginal donors.

Physiology

Microcirculatory Processes

Capillaries serve as the primary site of nutrient and in the microcirculation, consisting of a single layer of endothelial cells surrounded by a . Endothelial cells form a thin, continuous barrier that regulates the passage of molecules and cells between the bloodstream and tissues, adapting to local physiological demands through processes like . The , composed of proteins such as and IV, provides and acts as a selective filter, influencing permeability and maintaining vascular integrity during perfusion. Fluid exchange across the capillary wall is governed by forces, which balance hydrostatic and oncotic s to determine net or absorption. Hydrostatic within the (Pc) drives fluid outward, while interstitial hydrostatic (Pi) opposes it; conversely, oncotic pressures (πc in plasma and πi in ) due to plasma proteins promote fluid retention. This dynamic is quantified by the equation: Jv=Kf[(Pc−Pi)−σ(πc−πi)]J_v = K_f \left[ (P_c - P_i) - \sigma (\pi_c - \pi_i) \right] where JvJ_v is the transendothelial flow rate, KfK_f is the filtration coefficient reflecting capillary permeability and surface area, and σ\sigma is the indicating solute permeability. In continuous capillaries, such as those in muscle, this mechanism ensures controlled exchange, with net filtration at the arterial end and absorption at the venular end, preventing excessive fluid loss. Arterioles and venules contribute to microcirculatory perfusion by modulating capillary recruitment and flow distribution. Precapillary sphincters, located at the junction of terminal arterioles and capillaries, act as gatekeepers that open or close in response to local metabolic signals, thereby regulating the number of perfused capillaries and optimizing oxygen delivery. These sphincters relax in the presence of vasodilatory metabolites like , which accumulates during tissue hypoxia or increased metabolic activity, and (NO), produced by endothelial cells in response to , enhancing and blood flow. This local control ensures that perfusion matches tissue demand without relying on broader systemic adjustments. Tissue perfusion exhibits significant heterogeneity across organs and within zonal structures, reflecting adaptations to specific functional needs. In the liver, sinusoids—specialized discontinuous capillaries—feature fenestrated endothelial cells with pores (100–200 nm) grouped in sieve plates, lacking a continuous basement membrane, which allows direct exchange between blood and hepatocytes in the space of Disse. This structure results in zonal variations, with higher porosity (up to 8%) in centrilobular regions compared to periportal zones (around 6%), facilitating nutrient uptake from dual blood supplies but introducing variable flow velocities (400–450 μm/s). In contrast, skeletal muscle capillaries have continuous endothelium with tight junctions and a prominent basement membrane, promoting uniform diffusion over short distances (about 1 μm to fibers) at higher velocities (500–1,000 μm/s), prioritizing efficient oxygen delivery during contraction. Such differences underscore how microvascular architecture tailors perfusion to organ-specific roles, from filtration in the liver to metabolic support in muscle. The endothelial , a gel-like layer coating the luminal surface of endothelial cells, further refines perfusion by serving as a protective barrier against excessive fluid and solute leakage. Composed primarily of proteoglycans (e.g., syndecans and glypicans bearing chains like , comprising 50–90% of the structure) and glycoproteins (e.g., selectins and with branched moieties), the extends 0.2–0.5 μm into the lumen, creating an exclusion zone for red blood cells and modulating permeability through charge and . This composition enables selective transport, repelling larger molecules while permitting small solutes, thus maintaining vascular and preventing during normal perfusion.

Regulation Mechanisms

Perfusion in tissues is tightly regulated by a combination of intrinsic and extrinsic mechanisms to ensure adequate oxygen and delivery while matching metabolic demands. These controls operate at local, neural, hormonal, and endothelial levels, maintaining stable blood flow despite fluctuations in systemic pressure or tissue activity. Intrinsic autoregulation, for instance, allows vascular beds to adjust resistance independently of central influences, primarily through myogenic and metabolic pathways. Autoregulation is a fundamental intrinsic mechanism that stabilizes tissue perfusion across a range of perfusion s, typically between 60 and 160 mmHg in many organs. The myogenic response involves vascular contraction in response to increased intraluminal , which stretches the vessel wall and triggers via mechanosensitive channels, thereby increasing resistance to prevent excessive flow. Complementing this, metabolic feedback adjusts perfusion based on tissue oxygen and metabolite levels; for example, hypoxia induces through the hypoxia-inducible factor 1α (HIF-1α) pathway, which upregulates genes for and production, enhancing blood flow to hypoxic regions. These processes ensure that cerebral and renal perfusion, among others, remains constant during moderate changes. Neural control provides extrinsic modulation, predominantly via the , to redistribute perfusion during systemic needs like exercise or stress. Sympathetic activation causes in most vascular beds through α-adrenergic receptors on , releasing norepinephrine that binds to these G-protein-coupled receptors, elevating intracellular calcium and promoting contraction; this diverts blood from and cutaneous areas to muscles and vital organs. In contrast, parasympathetic innervation, though limited to specific beds like coronary and cerebral vessels, induces dilation via muscarinic receptors that stimulate release from , increasing flow during rest or . Hormonal influences further fine-tune perfusion on a longer timescale, integrating signals from the renin-angiotensin-aldosterone system and cardiac peptides. Angiotensin II, produced in response to low renal perfusion, acts as a potent vasoconstrictor by binding AT1 receptors on vascular , initiating C-mediated that enhances resistance and maintains systemic pressure. Conversely, (ANP), secreted by atrial myocytes during volume expansion, promotes by activating receptors, increasing cyclic GMP to relax and reduce , thereby improving and tissue perfusion. Endothelial cells serve as a dynamic interface for local regulation, sensing hemodynamic forces and releasing vasoactive substances. Shear stress from increased blood flow activates mechanosensors like PECAM-1 and VEGFR2, leading to phosphorylation cascades that stimulate endothelial nitric oxide synthase (eNOS) to produce nitric oxide (NO), which diffuses to smooth muscle to induce relaxation and flow-mediated dilation. This mechanism is crucial for matching perfusion to increased metabolic demand, such as in exercising skeletal muscle, where sustained shear promotes sustained vasodilation. The relationship between perfusion pressure, flow, and resistance is mathematically described by Poiseuille's law, which models in rigid tubes and underscores how vascular dominates resistance. The resistance RR to flow is given by R=8ηLπr4R = \frac{8 \eta L}{\pi r^4} where η\eta is blood , LL is vessel length, and rr is ; thus, flow Q=ΔP/RQ = \Delta P / R (analogous to ) highlights that small changes in profoundly affect perfusion, linking regulatory mechanisms to pressure-flow dynamics.

Pathophysiology

Malperfusion

Malperfusion refers to inadequate blood flow through a , resulting in cellular or organ , inadequate oxygenation, , or . It arises from a mismatch between tissue perfusion supply and metabolic demand, leading to ischemia when oxygen delivery falls below requirements for aerobic . Malperfusion can be classified as global or regional, and as acute or chronic. Global malperfusion involves widespread systemic hypoperfusion, such as in hypovolemic or , where overall fails to meet bodily demands. Regional malperfusion affects specific vascular territories, for example, due to obstructing localized blood supply. Acute forms develop rapidly, often within minutes, as in thromboembolic events, while chronic malperfusion evolves gradually, as seen in progressive atherosclerotic narrowing. At the cellular level, malperfusion triggers rapid ATP depletion due to halted and reliance on anaerobic glycolysis. This shift causes accumulation of , resulting in intracellular and impaired enzyme function. Prolonged ischemia leads to irreversible , with timelines varying by tissue. In the , vulnerable neurons like those in the hippocampus can suffer irreversible damage within 5 minutes of complete ischemia, while the myocardium typically withstands 20-40 minutes before ensues, as membrane integrity fails and ion pumps cease. Diagnostic indicators of malperfusion include elevated tissue or venous lactate levels exceeding 2 mmol/L, signaling anaerobic from hypoperfusion, and tissue below 7.2, reflecting severe . These markers help identify ischemic states but require correlation with clinical context. Malperfusion represents one end of a perfusion spectrum; the opposite extreme includes hyperperfusion syndromes, where abrupt restoration of flow to chronically hypoperfused tissues causes , , and hemorrhage due to impaired autoregulation.

Causes and Consequences

Perfusion deficits frequently originate from vascular pathologies that compromise arterial integrity and blood flow. Atherosclerosis, the progressive accumulation of lipid-rich plaques within arterial walls, narrows lumens and reduces downstream perfusion, particularly affecting high-demand organs like the heart and brain. Vasospasm, involving abrupt and intense contraction of vascular smooth muscle, transiently occludes vessels and induces localized ischemia, as seen in coronary vasospastic angina where endothelial dysfunction exacerbates the response. Thromboembolism, the embolization of thrombi from proximal sites, acutely blocks distal vasculature; a prominent example is carotid artery occlusion leading to cerebral hypoperfusion and ischemic stroke, where clot propagation halts oxygen delivery to hemispheric territories. Cardiac sources of perfusion impairment stem from conditions that curtail effective blood ejection. In heart failure with reduced ejection fraction—defined as less than 40%—myocardial dysfunction diminishes and overall , resulting in systemic underperfusion and tissue hypoxia. This output deficit activates compensatory mechanisms like neurohormonal surges but ultimately fails to maintain adequate organ-level blood flow, perpetuating a cycle of worsening ischemia. Systemic etiologies further contribute to global hypoperfusion through volume or distribution imbalances. , commonly induced by acute hemorrhage, depletes intravascular volume and reduces venous return, thereby lowering cardiac preload and tissue oxygenation. , characterized by cytokine-mediated and capillary leak, creates a relative hypovolemic state with maldistributed flow, severely limiting microvascular perfusion despite normal or elevated . The repercussions of sustained perfusion deficits manifest as multi-organ dysfunction syndrome (MODS), a progressive cascade where initial hypoperfusion induces cellular energy failure, inflammation, and sequential organ involvement. Critical timelines underscore the urgency: in the , complete ischemia triggers irreversible neuronal death in vulnerable regions like the hippocampus within 5 minutes, escalating to widespread by 10–20 minutes. MODS often evolves from such hypoxic insults, compounded by endothelial damage and microvascular , leading to renal, hepatic, and pulmonary failures if uncorrected. Restoration of perfusion, while essential, can provoke , wherein reintroduction of oxygen generates cytotoxic free radicals through pathways like conversion of hypoxanthine to . This oxidative burst amplifies tissue necrosis, , and inflammatory mediator release, paradoxically extending damage beyond the initial ischemic period in organs such as the myocardium and kidneys.

Measurement Techniques

Microsphere Methods

The microsphere method is an invasive technique used to quantify regional tissue perfusion by injecting microspheres into the arterial circulation, where they become trapped in the microvasculature in proportion to flow. Typically, microspheres ranging from 15 to 50 μm in , often radiolabeled with isotopes such as ^{141}Ce, ^{85}Sr, or ^{46}Sc, are suspended in a carrier solution and injected directly into the left atrium, left ventricle, or a major to ensure uniform mixing with the bloodstream. Once circulated, these microspheres lodge in precapillary arterioles and capillaries, with their distribution reflecting local perfusion rates; particles smaller than 10 μm may pass through some beds, while larger ones (up to 50 μm) provide better retention but risk partial shunting in high-flow organs like the lungs or kidneys. Following injection, a reference sample is withdrawn at a known rate (typically 5-10 mL/min) from a peripheral , such as the femoral, to normalize measurements against total . Perfusion is calculated using the ratio of microspheres recovered in a tissue sample to those in the reference sample, scaled by the withdrawal rate. The formula for regional blood flow QQ (in mL/min/g) is: Q=NtNr×RwQ = \frac{N_t}{N_r} \times \frac{R}{w} where NtN_t is the number of microspheres (or radioactivity counts) in the tissue sample, NrN_r is the number in the reference sample, RR is the reference withdrawal rate (mL/min), and ww is the tissue weight in grams. For reliable accuracy within 10% of true values, at least 400 microspheres must be present per tissue sample, necessitating careful dose titration (e.g., 1-5 × 10^6 spheres total) to avoid aggregation or embolization. Post-experiment, tissues are excised, weighed, and analyzed via gamma scintillation counting for radioactive labels or fluorescence spectroscopy for non-radioactive variants. This method finds primary applications in animal research for studying regional organ perfusion, such as myocardial blood flow distribution in models of ischemia or , and in intraoperative cardiac studies during open-heart procedures in experimental settings to assess real-time coronary reserve. In and canine models, it has enabled detailed mapping of subendocardial versus subepicardial flows, revealing heterogeneity under stress conditions like exercise or pharmacological . Key advantages include high spatial resolution down to samples as small as 50 mg, allowing introrgan perfusion gradients, and the ability to perform multiple sequential measurements (up to 8-13 with distinct labels) in the same subject. However, it requires for full analysis in most cases or invasive catheterization in intraoperative use, limiting clinical translation; from isotopes poses handling risks, and uneven distribution can occur if mixing is incomplete. In the 2020s, there has been a notable shift toward fluorescent microspheres (e.g., beads labeled with dyes like yellow-green or ), which eliminate radioactivity while maintaining comparable accuracy through automated detection, facilitating safer chronic and small-animal studies.

Nuclear Medicine Approaches

Nuclear medicine approaches to perfusion assessment utilize scintigraphic techniques with radiotracers to evaluate blood flow dynamically in organs such as the heart, providing functional insights into tissue perfusion. These methods involve the intravenous administration of short-lived radioisotopes that distribute according to regional blood flow, followed by imaging to capture tracer uptake and distribution. Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are the primary modalities, offering both qualitative and quantitative evaluation of perfusion defects. A key SPECT technique employs sestamibi (99mTc-sestamibi) for , where the tracer is taken up by myocardial cells in proportion to blood flow. In PET, ammonia (13N-ammonia) serves as a widely used tracer for quantitative assessment of coronary blood flow, enabling measurement of absolute myocardial blood flow (MBF) values. These tracers are selected for their favorable biodistribution, allowing differentiation between normal and ischemic tissues based on flow-dependent uptake. The standard protocol begins with intravenous injection of the radiotracer, typically under rest conditions, followed by imaging using a for SPECT or a PET scanner. For 99mTc-sestamibi SPECT, doses range from 8 to 12 mCi at rest, with imaging acquired 30 to post-injection to allow for myocardial uptake; stress imaging (via exercise or pharmacologic agents like ) follows with a higher dose (up to 30-40 mCi) and similar acquisition timing. In 13N-ammonia PET protocols, 10-20 mCi is injected for both rest and stress phases, with dynamic imaging starting immediately after injection to capture the first-pass transit, often completed within 25- total. Analysis involves generating time-activity curves from dynamic to model tracer kinetics and derive perfusion parameters. Quantification in these approaches focuses on the uptake rate of the tracer, which correlates directly with blood flow; for instance, 13N-ammonia PET yields absolute MBF in units of mL/g/min, with normal resting values around 0.8-1.2 mL/g/min and stress values exceeding 2.5 mL/g/min indicating preserved flow reserve. In SPECT with 99mTc-sestamibi, semi-quantitative indices like the summed stress score assess relative perfusion, while advanced dynamic protocols enable absolute flow estimation comparable to PET. These metrics provide a robust measure of perfusion heterogeneity, outperforming relative assessments in detecting multivessel . Clinically, these techniques are applied in stress-rest protocols to detect ischemia, where reduced tracer uptake during stress relative to rest signifies flow-limiting . For example, 99mTc-sestamibi SPECT identifies reversible perfusion defects with high sensitivity (85-90%) for significant stenoses, guiding decisions. Similarly, 13N-ammonia PET offers superior accuracy (up to 95%) for quantifying coronary flow reserve, stratifying risk in patients with suspected or known . Despite their efficacy, perfusion imaging carries limitations, including exposure to from the radiotracers, with effective doses typically 10-15 mSv for SPECT and 5-10 mSv for PET protocols, necessitating dose optimization strategies. Additionally, is lower (approximately 10-15 mm for SPECT and 4-6 mm for PET) compared to non-ionizing modalities like MRI, potentially limiting detection of small perfusion abnormalities. Access to on-site cyclotrons for 13N-ammonia production further restricts widespread use.

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) provides a non-invasive means to assess tissue perfusion through techniques that exploit changes in magnetic resonance signals influenced by blood flow and contrast agents. Dynamic contrast-enhanced (DCE) MRI involves the intravenous administration of gadolinium-based contrast agents, which alter the T1 relaxation time of and tissues, allowing for the mapping of perfusion parameters such as cerebral blood flow (CBF) and . This method captures rapid serial images during the first pass of the contrast bolus, enabling quantitative evaluation of microvascular perfusion in various organs. An alternative non-contrast approach is arterial spin labeling (ASL), which magnetically tags inflowing protons as an endogenous tracer to measure perfusion without exogenous agents. In ASL, typically applied to cerebral perfusion, inversion pulses selectively label blood in feeding arteries, and the difference between labeled and control images yields perfusion-weighted signals. This technique is particularly useful for brain imaging, providing absolute CBF quantification in milliliters per 100 grams per minute, and avoids risks associated with contrast media. Analysis of MRI perfusion data involves processing time-series signal intensity curves to derive key parameters. In both DCE and ASL methods, of tissue signals with an arterial input function informs perfusion metrics, often using adaptations of the Kety model for CBF estimation. These parameters allow for voxel-wise mapping of perfusion heterogeneity, aiding in the identification of ischemic or hyperperfused regions. In clinical applications, MRI perfusion excels in evaluation by delineating salvageable penumbra through mismatch between diffusion and perfusion deficits, guiding thrombolytic or endovascular therapies. For tumor , DCE-MRI quantifies and flow, correlating elevated transfer coefficients with neovascularization in gliomas and other malignancies, which informs anti-angiogenic treatment responses. Key advantages include the absence of , reducing cumulative exposure risks, and the multi-parametric nature that simultaneously assesses flow, volume, and permeability for comprehensive tissue characterization. Recent advances in the 2020s have introduced 4D flow MRI, which extends phase-contrast techniques to provide time-resolved, three-dimensional velocity mapping of vascular structures, enhancing perfusion assessment in complex anatomies like the or . This method facilitates detailed hemodynamic analysis, including wall and flow vortices, with improved acceleration schemes enabling routine clinical use.

Computed Tomography

Computed tomography (CT) perfusion imaging is a functional technique that enables rapid, volumetric evaluation of tissue flow by tracking the passage of an agent bolus through the vascular bed. The method involves intravenous injection of a high-concentration medium, followed by dynamic serial acquisition of CT slices during the arterial phase, typically using bolus-tracking software to initiate scanning once a threshold enhancement is detected in a reference . This approach captures time-density curves for arteries, veins, and tissue , allowing for the computation of perfusion metrics across multiple slices or volumes in modern multidetector CT systems. Perfusion parameters are derived from these time-density curves using mathematical models, which separate the effects of arterial input and tissue functions to estimate key hemodynamic values. Central (CBV) quantifies the volume of blood in the tissue microvasculature, Transit Time (MTT) measures the average time for blood to pass through the bed, and Cerebral Flow (CBF) is calculated as the CBF = CBV / MTT, providing an indicator of perfusion rate. These parameters are generated as color-coded maps, with thresholds aiding in the identification of ischemic or hyperperfused regions; for instance, prolonged MTT and reduced CBF are hallmarks of hypoperfusion. In clinical practice, CT perfusion is widely applied in acute ischemic triage to delineate salvageable penumbra from infarct core, guiding decisions for or within time-sensitive windows. In , it assesses tumor and viability, particularly for monitoring treatment response in hepatic, colorectal, or head-and-neck malignancies, where elevated CBF and CBV correlate with aggressive, perfused lesions versus necrotic areas. The technique's high supports whole-brain coverage in under 60 seconds, making it suitable for emergency settings, though it contrasts with MRI's non-ionizing approach preferred in . Key advantages include its speed—enabling acquisition in less than one minute—and broad availability on standard CT scanners, facilitating rapid integration into acute workflows without specialized hardware. However, limitations encompass significant , typically ranging from 4 to 15 mSv per study with modern protocols (as of 2025), though older or non-optimized scans may reach up to 20-25 mSv, alongside risks of contrast-induced nephropathy, particularly in patients with renal impairment or , where incidence may reach 3-5% in contexts. As of 2025, AI-enhanced reconstruction techniques enable ultra-low-dose CT perfusion protocols, reducing effective doses to under 3 mSv while maintaining diagnostic accuracy. Strategies such as dose-optimized protocols and hydration mitigate these concerns, but careful patient selection remains essential.

Thermal Diffusion

Thermal diffusion flowmetry, also known as the thermal clearance method, employs a specialized to measure local tissue perfusion by quantifying dissipation. The , typically consisting of two s spaced a few millimeters apart—one serving as a to measure baseline tissue and the other actively heated— is inserted into the tissue of interest. Perfusion is inferred from the rate at which flow carries away from the warmed , as higher flow accelerates cooling and reduces the steady-state difference between the thermistors. This principle relies on the convective by overriding conductive loss in perfused tissues, allowing real-time assessment of microcirculatory flow in absolute units such as ml/100 g/min. The perfusion value is derived from the thermal conductivity of the tissue, which increases linearly with blood flow rate. A common formulation expresses effective thermal conductivity keffk_{\text{eff}} as keff=k0+βwk_{\text{eff}} = k_0 + \beta w, where k0k_0 is the baseline tissue conductivity without perfusion, β\beta is an empirically determined constant, and ww is the perfusion rate; the probe measures keffk_{\text{eff}} via the electrical power PP supplied to maintain a fixed temperature offset ΔT\Delta T, approximated as keff∝P/ΔTk_{\text{eff}} \propto P / \Delta T. Calibration is performed empirically using known flow rates in phantom models or animal tissues to account for variations in tissue properties, ensuring accuracy within 10-20% for specific applications. This technique finds primary use in intraoperative monitoring, such as during neurosurgical procedures where the probe is placed in brain parenchyma to track regional cerebral blood flow changes in response to interventions like clipping or tumor resection. In critical care settings, it enables continuous bedside surveillance of perfusion in high-risk patients, such as those with , to detect ischemia early and guide hemodynamic management. Representative studies have validated its sensitivity, showing rCBF increases from 49 to 120 ml/100 g/min during challenges. Key advantages include its ability to provide continuous, quantitative point measurements with high (seconds) and minimal invasiveness relative to larger implants, facilitating integration into multimodal neuromonitoring arrays. However, it is limited to superficial local assessments, typically sampling a volume of 1-2 mm depth around the tip, and its readings can be influenced by heterogeneous tissue conductivity and , necessitating site-specific .

Clinical Applications

Surgical Perfusion

Surgical perfusion refers to the techniques employed during operative procedures to maintain adequate flow and oxygenation to tissues and organs, preventing ischemia and supporting physiological functions under controlled conditions. These methods are essential in complex surgeries where normal circulation is interrupted, such as cardiac operations or . Key approaches include for systemic support, isolated limb perfusion for localized tumor treatment, and hypothermic machine perfusion for organ preservation, each tailored to specific surgical needs while minimizing complications like . Cardiopulmonary bypass (CPB) is a cornerstone of , utilizing an extracorporeal circuit to temporarily take over heart and functions. The circuit typically comprises a venous for blood collection, a centrifugal or roller pump to propel blood, an to facilitate , a for temperature regulation, and arterial filters to remove debris. Standard non-pulsatile flow rates during normothermic CPB are maintained at 2.2-2.4 L/min/m² of to ensure adequate oxygen delivery, adjusted based on patient and temperature. Anticoagulation is achieved primarily with unfractionated , administered at an initial dose of 300-400 IU/kg to maintain activated clotting times above 480 seconds, preventing formation in the circuit. Isolated limb perfusion (ILP) is a targeted technique used primarily for treating in-transit metastases of in the extremities, isolating the limb's circulation to deliver high-dose without systemic exposure. The procedure involves cannulating the major artery and vein, clamping collateral vessels, and perfusing the limb with a warmed solution containing (typically 10-13 mg/L of limb volume) under mild at 39-40°C for 60-90 minutes, often combined with tumor factor-alpha to enhance antitumor effects. This hyperthermic approach improves drug penetration and cytotoxicity, achieving complete response rates of approximately 50-70% as reported in clinical studies and meta-analyses for melanoma in-transit metastases. In , hypothermic machine perfusion (HMP) preserves s by continuously circulating a cold preservation solution through the renal vasculature, mitigating ischemic damage during storage. Performed at 4°C, HMP uses pulsatile or non-pulsatile flows of 1-2 mL/min/g of kidney weight to maintain low and delivery, reducing the incidence of delayed graft function compared to static cold storage, particularly for extended criteria donors. Clinical trials and meta-analyses have demonstrated approximately a 40% relative reduction (OR 0.59-0.70) in delayed graft function rates with HMP, improving one-year graft survival. Intraoperative monitoring of perfusion is critical, with near-infrared spectroscopy (NIRS) providing noninvasive assessment of cerebral oxygenation by measuring regional oxygen saturation in the frontal cortex. NIRS detects desaturations below 50% as indicators of inadequate cerebral perfusion, guiding adjustments in CPB flow or during . This technique correlates with jugular venous oxygen saturation and has been associated with reduced neurological complications when interventions are applied promptly. A major complication of CPB is the (SIRS), triggered by blood-circuit contact, leading to release, endothelial activation, and potential multi-organ dysfunction. This response affects up to 30% of patients, manifesting as fever, , and prolonged ventilation, with risk factors including prolonged bypass duration and . Strategies to mitigate SIRS include biocompatible circuit coatings and administration, though outcomes vary.

Therapeutic Interventions

Therapeutic interventions for perfusion deficits aim to restore or enhance tissue blood flow through non-surgical means, primarily targeting acute and chronic conditions such as shock, ischemia, and vascular insufficiency. These approaches include pharmacological agents that modulate vascular tone, mechanical devices that support , adjunctive therapies like hyperbaric oxygen to boost oxygen delivery, and emerging regenerative strategies using stem cells to promote neovascularization. While effective in stabilizing and promoting healing in select cases, outcomes vary, with evidence from randomized trials underscoring the need for patient-specific application to avoid limited or adverse effects. Pharmacological interventions focus on vasopressors and vasodilators to optimize perfusion pressure and flow. In , norepinephrine is the first-line vasopressor, recommended to achieve a (MAP) target of at least 65 mmHg, as this threshold supports organ perfusion without excessive . This guideline stems from the Surviving Sepsis Campaign, which emphasizes early initiation to reduce mortality in vasodilatory shock states. Conversely, vasodilators like are employed in angina pectoris to relieve myocardial ischemia by dilating and reducing preload, thereby improving subendocardial perfusion during episodes of . Sublingual or intravenous administration provides rapid relief, with guidelines endorsing its use in acute coronary syndromes to balance oxygen supply and demand. Mechanical support, such as the (IABP), addresses by counterpulsation to augment diastolic coronary perfusion and reduce systolic . The device inflates in the during , increasing coronary artery pressure by up to 20-30%, and deflates during to lower left ventricular workload. Despite its physiological rationale, clinical evidence from the IABP-SHOCK II trial demonstrated no significant mortality benefit at 30 days or one year in patients with myocardial infarction-related shock, leading to downgraded recommendations in current guidelines against routine use. Hyperbaric oxygen therapy (HBOT) enhances perfusion-independent oxygen delivery in hypoxic wounds, particularly diabetic foot ulcers, by increasing plasma-dissolved oxygen to partial pressures of approximately 2000 mmHg at 2-3 atmospheres absolute (ATA). This elevates tissue oxygenation in poorly vascularized areas, promoting , synthesis, and bacterial clearance, with Undersea and Hyperbaric Medical Society guidelines supporting its adjunctive role for Wagner grade 3+ ulcers unresponsive to standard care. Systematic reviews indicate improved healing rates by 20-30% compared to conventional alone, reducing amputation risk in chronic cases. Stem cell therapies, particularly those involving endothelial cells (EPCs), represent a regenerative approach to enhance perfusion in (PAD) by stimulating and arteriogenesis. In 2020s clinical trials, autologous EPCs derived from or peripheral blood have been infused to mobilize and differentiate into endothelial cells, improving limb perfusion as measured by ankle-brachial index and transcutaneous oxygen pressure. Phase II studies, such as those reviewed in recent meta-analyses, report modest gains in pain-free walking distance and ulcer healing, though larger randomized trials are needed to confirm long-term efficacy and safety. Recent phase II/III trials as of 2024-2025, including mesenchymal stromal cell therapies like REGENACIP®, continue to report improvements in limb perfusion and ulcer healing in chronic limb-threatening ischemia. Overall outcomes of these interventions highlight variable impacts on mortality and perfusion restoration. For instance, the IABP-SHOCK II trial (2012) found no reduction in 30-day all-cause mortality (39.7% with IABP vs. 41.3% without), despite hemodynamic improvements, influencing a shift toward more targeted mechanical supports like in refractory cases. Pharmacological strategies in achieve MAP goals in over 80% of patients but do not universally lower mortality without bundled care. HBOT and approaches show promise for chronic ischemia, with healing rates up to 75% in responsive subgroups, yet cost-effectiveness and accessibility remain challenges.

References

  1. https://college.mayo.edu/academics/explore-health-care-careers/careers-a-z/cardiovascular-perfusionist/
  2. https://radiopaedia.org/articles/cerebral-blood-flow-cbf?lang=us
  3. https://radiopaedia.org/articles/cerebral-hyperperfusion-syndrome?lang=us
  4. https://jnm.snmjournals.org/content/55/3/522
  5. https://www.ahajournals.org/doi/10.1161/circimaging.109.855981
  6. https://pubmed.ncbi.nlm.nih.gov/33349946/
  7. https://www.ncbi.nlm.nih.gov/books/NBK539907/
  8. https://pubmed.ncbi.nlm.nih.gov/23949407/
  9. https://www.etymonline.com/word/perfusion
  10. https://link.springer.com/article/10.1007/s00259-018-3982-7
  11. http://www.turkupetcentre.net/petanalysis/model_perfusion.html
  12. https://www.differencebetween.com/difference-between-perfusion-and-vs-diffusion/
  13. https://www.ncbi.nlm.nih.gov/books/NBK470455/
  14. https://www.ncbi.nlm.nih.gov/books/NBK54473/
  15. https://www.vhlab.umn.edu/atlas/physiology-tutorial/cardiovascular-function.shtml
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC6852121/
  17. https://www.ncbi.nlm.nih.gov/books/NBK560729/
  18. https://www.ncbi.nlm.nih.gov/books/NBK542252/
  19. https://pubmed.ncbi.nlm.nih.gov/25564234/
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC12331573/
  21. https://pubmed.ncbi.nlm.nih.gov/21781247/
  22. https://www.hellenicjcardiol.org/archive/full_text/2015/3/2015_3_197.pdf
  23. https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.119.314977
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC2776239/
  25. https://link.springer.com/article/10.1007/BF02281906
  26. https://pubmed.ncbi.nlm.nih.gov/8832128/
  27. https://www.sciencedirect.com/science/article/pii/S2214854X24000244
  28. https://physoc.onlinelibrary.wiley.com/doi/pdfdirect/10.1113/expphysiol.1977.sp002369
  29. https://www.massgeneral.org/anesthesia/news/ether-175
  30. https://journals.physiology.org/doi/full/10.1152/physiologyonline.1998.13.4.203
  31. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.108.830174
  32. https://pubmed.ncbi.nlm.nih.gov/7052001/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC4324810/
  34. https://doi.org/10.1097/00004728-197910000-00013
  35. https://pubmed.ncbi.nlm.nih.gov/26752191/
  36. https://www.ncbi.nlm.nih.gov/books/NBK26848/
  37. https://www.ncbi.nlm.nih.gov/books/NBK53447/
  38. https://www.ncbi.nlm.nih.gov/books/NBK53101/
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC131011/
  40. https://www.ahajournals.org/doi/10.1161/01.res.0000255690.03436.ae
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC1915585/
  42. https://www.tabers.com/tabersonline/view/Tabers-Dictionary/776299/0/malperfusion
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC7137753/
  44. https://www.annalsthoracicsurgery.org/article/S0003-4975%2822%2901392-3/fulltext
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC4876056/
  46. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.031264
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC3904795/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC381398/
  49. https://www.ncbi.nlm.nih.gov/books/NBK470202/
  50. https://www.ahajournals.org/doi/10.1161/01.str.0000149946.86087.e5
  51. https://www.ncbi.nlm.nih.gov/books/NBK535419/
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC12029111/
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC5075799/
  54. https://www.ncbi.nlm.nih.gov/books/NBK430873/
  55. https://www.ncbi.nlm.nih.gov/books/NBK513297/
  56. https://www.ncbi.nlm.nih.gov/books/NBK470316/
  57. https://pubmed.ncbi.nlm.nih.gov/24295608/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC4857933/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC2149484/
  60. https://pubmed.ncbi.nlm.nih.gov/16580655/
  61. https://journals.physiology.org/doi/full/10.1152/ajpheart.00834.2016
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC3483311/
  63. https://www.annalsthoracicsurgery.org/article/S0003-4975(10)63850-7/fulltext
  64. https://www.sciencedirect.com/science/article/pii/S221418042500131X
  65. https://jnm.snmjournals.org/content/54/8/1485
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC4333146/
  67. https://tech.snmjournals.org/content/36/3/155
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC9553851/
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC5994394/
  70. https://www.ncbi.nlm.nih.gov/books/NBK539772/
  71. https://pmc.ncbi.nlm.nih.gov/articles/PMC6382649/
  72. https://www.asnc.org/wp-content/uploads/2024/06/Rec-for-Reducing-Radiation-Expo-in-MPI.pdf
  73. https://jnm.snmjournals.org/content/56/4/592
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC3996240/
  75. https://i-mri.org/DOIx.php?id=10.13104/imri.2022.26.4.256
  76. https://pubs.rsna.org/doi/abs/10.1148/rg.220088
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC2999014/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC3341512/
  79. https://www.ahajournals.org/doi/10.1161/STROKEAHA.119.028337
  80. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168632
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC4170157/
  82. https://pmc.ncbi.nlm.nih.gov/articles/PMC10895087/
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC7051780/
  84. https://pmc.ncbi.nlm.nih.gov/articles/PMC3166726/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC7964979/
  86. https://pmc.ncbi.nlm.nih.gov/articles/PMC4263626/
  87. https://firstwordhealthtech.com/story/5980624
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC7758765/
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC5126301/
  90. https://pubmed.ncbi.nlm.nih.gov/24378887/
  91. https://pmc.ncbi.nlm.nih.gov/articles/PMC6998001/
  92. https://pmc.ncbi.nlm.nih.gov/articles/PMC2596616/
  93. https://thejns.org/view/journals/j-neurosurg/93/2/article-p265.xml
  94. https://pmc.ncbi.nlm.nih.gov/articles/PMC2701710/
  95. https://pubmed.ncbi.nlm.nih.gov/10930012/
  96. https://www.sciencedirect.com/topics/immunology-and-microbiology/thermal-diffusion
  97. https://pmc.ncbi.nlm.nih.gov/articles/PMC5613602/
  98. https://journals.lww.com/ijaweb/fulltext/2017/61090/basics_of_cardiopulmonary_bypass.10.aspx
  99. https://anaesthetics.ukzn.ac.za/wp-content/uploads/2024/08/2024-08-02-Cardioplumonary-bypass-for-the-Anaesthetist-A-Kajee.pdf
  100. https://ject.edpsciences.org/articles/ject/pdf/1990/04/ject1990224p165.pdf
  101. https://pmc.ncbi.nlm.nih.gov/articles/PMC9947996/
  102. https://pubmed.ncbi.nlm.nih.gov/20204294/
  103. https://pmc.ncbi.nlm.nih.gov/articles/PMC9845483/
  104. https://pubmed.ncbi.nlm.nih.gov/7695980/
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC1356509/
  106. https://pmc.ncbi.nlm.nih.gov/articles/PMC3227960/
  107. https://pmc.ncbi.nlm.nih.gov/articles/PMC10488768/
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC6503225/
  109. https://pmc.ncbi.nlm.nih.gov/articles/PMC6247599/
  110. https://pmc.ncbi.nlm.nih.gov/articles/PMC8043988/
  111. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699221/
  112. https://pmc.ncbi.nlm.nih.gov/articles/PMC6491319/
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC9303696/
  114. https://pubmed.ncbi.nlm.nih.gov/11565890/
  115. https://pubmed.ncbi.nlm.nih.gov/30772177/
  116. https://www.ncbi.nlm.nih.gov/books/NBK482382/
  117. https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-guidelines-2021
  118. https://www.uptodate.com/contents/nitrates-in-the-management-of-acute-coronary-syndrome
  119. https://www.aats.org/tsra-primer-intra-aortic-balloon-pump
  120. https://www.nejm.org/doi/full/10.1056/NEJMoa1208410
  121. https://journals.lww.com/mgar/fulltext/2021/11010/therapeutic_effects_of_hyperbaric_oxygen_.6.aspx
  122. https://www.uhms.org/images/CPG/UHM_42-3_CPG_for_DFU.pdf
  123. https://pmc.ncbi.nlm.nih.gov/articles/PMC7950353/
  124. https://pmc.ncbi.nlm.nih.gov/articles/PMC7357605/
  125. https://pmc.ncbi.nlm.nih.gov/articles/PMC6960121/
  126. https://stemcellres.biomedcentral.com/articles/10.1186/s13287-024-03957-0
Add your contribution
Related Hubs
User Avatar
No comments yet.